Repurposing trifluoperazine as a potential therapeutic agent for ovarian cancer: mechanistic insight via SRC/PI3K/AKT signaling pathway inhibition

Quan He(Nanchang University), Yuanqiao He(Nanchang University)
Journal of Ovarian Research
February 4, 2026
Cited by 0


Related Papers